Company Filing History:
1 out of 290 
1 out of 8 Years Active: 2014
Title: The Innovative Contributions of Marc Bertrand
Introduction
Marc Bertrand, an accomplished inventor based in Saint Jean le Blanc, France, has made significant strides in the field of pharmaceuticals. With a keen focus on addressing disorders related to ryanodine receptors (RyRs), his innovations aim to improve treatment options for various health conditions.
Latest Patents
Marc Bertrand holds a notable patent for "Agents for treating disorders involving modulation of ryanodine receptors." This invention revolves around 1,4-benzothiazepine derivatives, which have potential applications in treating diseases associated with RyRs that play a critical role in calcium channel regulation within cells. The patent also encompasses pharmaceutical compositions that utilize these compounds specifically for cardiac, musculoskeletal, and central nervous system disorders.
Career Highlights
Throughout his career, Marc has made valuable contributions while working with esteemed companies such as Les Laboratoires Servier and Armgo Pharma, Inc. His expertise in the pharmaceutical sector has allowed him to advance research and development in innovative treatments, placing him at the forefront of medical discoveries.
Collaborations
Marc has collaborated with prominent professionals in the field, including Jiaming Yan and Sandro Belvedere. These collaborations have enabled him to enhance the scope and impact of his innovative work, fostering an environment of creativity and scientific progress.
Conclusion
In summary, Marc Bertrand is a distinguished inventor whose work with ryanodine receptors has the potential to revolutionize treatment methodologies for various disorders. Through his patent and collaborative efforts, he continues to contribute to advancements in the pharmaceutical industry, showcasing the significant impact of innovation on healthcare solutions.